The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Importance of maintenance of dose intensity (DI) during 1st and 2nd line chemotherapy (CT) for nonresectable metastatic colorectal cancer (mCRC).
 
Mikhail Fedyanin
No Relationships to Disclose
 
Alexey Tryakin
No Relationships to Disclose
 
Ilya Pokataev
No Relationships to Disclose
 
Anna Popova
No Relationships to Disclose
 
Anatoly Bulanov
No Relationships to Disclose
 
Kheda Elsnukaeva
No Relationships to Disclose
 
Olga Sekhina
No Relationships to Disclose
 
Dzhennet Chekini
No Relationships to Disclose
 
Sergei Tjulandin
Stock and Other Ownership Interests - RosPharmTech
Speakers' Bureau - AstraZeneca; Lilly; Sanofi
Travel, Accommodations, Expenses - Boehringer Ingelheim; Roche